+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cardiac Glycosides"

From
From
Inotropic Agents Market Report 2025 - Product Thumbnail Image

Inotropic Agents Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Genetic Cardiomyopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Genetic Cardiomyopathies Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 200 Pages
  • Global
From
  • 14 Results (Page 1 of 1)
Loading Indicator

Cardiac glycosides are a class of drugs used to treat heart failure and abnormal heart rhythms. They work by increasing the force of contraction of the heart muscle, which helps the heart pump more efficiently. Cardiac glycosides are also used to treat certain types of arrhythmias, or irregular heartbeats. These drugs are typically prescribed in combination with other medications, such as diuretics and ACE inhibitors. Cardiac glycosides are an important part of the cardiovascular drug market. They are used to treat a variety of conditions, including heart failure, arrhythmias, and hypertension. They are also used to reduce the risk of stroke and other cardiovascular events. Cardiac glycosides are generally well-tolerated and have few side effects. Some of the companies in the cardiac glycoside market include Sanofi, Pfizer, Merck, and Novartis. These companies produce a variety of cardiac glycoside medications, including digoxin, lanatoside C, and ouabain. Show Less Read more